VIRX: Target median analis Viracta

Viracta Therapeutics (VIRX) develops targeted therapies for tumors caused by the Epstein-Barr virus, enabling the company to maintain significant pricing power within the rare disease niche. This daily price chart featuring the 0.00 metric reflects the current price action. An extensive patent portfolio and the integration of drugs into hospital protocols guarantee stable income, although the costs of bringing products to market are temporarily reducing overall profitability.

VIRX: Target konsensus Viracta 04.07.2022 - 16.02.2025

Rincian analitis perusahaan Viracta Therapeutics (VIRX)

Indikator analitis utama viracta.com (VIRX):

Bagan rega viracta.com|VIRX - Prakiraan konsensus analis|Kapitalisasi pasar Viracta

Analisis fundamental perusahaan:Viracta Therapeutics Inc. (VIRX)

Produk asli Viracta Therapeutics

For Viracta Therapeutics (VIRX), a leader in developing precision activators against lymphomas, the analyst consensus on the share price reflects the market valuation of its R&D platform's potential. This indicator aggregates expert price targets, serving as a barometer for asset revaluation during growth periods, where an upward trend confirms business strength while simultaneously signaling a reduction in the investment portfolio's margin of safety.

Perusahaan pesaing

Bagan rega target ONC (beigene.com)|Prakiraan konsensus analis HALO (Halozyme)|Target median analis Revolution Medicines Inc (RVMD)|AAPG - Bagan rega target|Konsensus nilai wajar CGON (CG Oncology Therapeutics)|URGN (UroGen Pharma Ltd.) - Target konsensus|Prakiraan gabungan firma investasi BCAX|PSNL (Personalis) - Prakiraan konsensus analis|Target konsensus Erasca Inc (ERAS)|Prakiraan konsensus analis DCTH|Prakiraan konsensus analis Y-mAbs Corp (YMAB)|Bagan rega target Aura Biosciences, Inc. AURA|CADL: Prakiraan gabungan firma investasi|Accuray - Prakiraan konsensus analis|SELLAS Life Sciences (SLS) - Target konsensus|ACTU: Prakiraan konsensus analis|Rata-rata rega prakiraan Citius Oncology Inc (CTOR)|Bagan rega target TuHURA Biosciences Inc.|TARA: Konsensus nilai wajar|Target konsensus FATE (Fate Therapeutics)|WHWK (aadibio.com) - Konsensus nilai wajar|Prakiraan konsensus analis TCRX (TScan Therapeutics, Inc.)|CSBR - Target konsensus|XBIT: Target konsensus|CVM - Prakiraan konsensus analis|OS Therapies (OSTX) - Bagan rega target|Radiopharm Theranostics Ltd - Konsensus nilai wajar|ARTV (Artiva Biotherapeutics Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan Adlai Nortye Limited ANL|Target konsensus VERU (Veru Inc.)|Bagan rega target TPST (tempesttx.com)|Prakiraan konsensus analis XLO (Xilio Therapeutics)|Target median analis Renovaro Biosciences (RENB)|MURA - Bagan rega target|Konsensus nilai wajar KAPA (Kairos Pharma Ltd)|OKUR: Prakiraan konsensus analis|CytoMed Therapeutics Limited (GDTC) - Prakiraan konsensus analis|CRIS (Curis Inc.) - Prakiraan konsensus analis|Target konsensus Apollomics Corp (APLM)|Target konsensus THAR (Tharimmune Corp)|Rega prakiraan analis ADVB|Prakiraan konsensus analis GNPX (Genprex, Inc.)|Prakiraan konsensus analis Calidi Biotherapeutics Inc. CLDI|SBFM: Target konsensus|Konsensus nilai wajar XBIO (Xenetic Biosciences)|SLRX (Salarius) - Target konsensus|PPBT: Rega prakiraan analis|AONC (American Oncology Network Inc) - Prakiraan konsensus analis|BGNE: Konsensus nilai wajar|Prakiraan konsensus analis CKPT|ELEV - Rata-rata rega prakiraan|Bagan rega target iCAD ICAD|Konsensus nilai wajar IKNA|Notable Labs, Ltd. - Prakiraan konsensus analis|MOR - Prakiraan konsensus analis|NAYA Biosciences Inc. (NAYA) - Bagan rega target|Bagan tingkat prakiraan AAPGV (Ascentage Pharma Group International)